Dr Jovan Stevovic is an entrepreneur, startup advisor and expert in health data protection and security. He is passionate about helping digital health innovation happen faster.
Since July 10th you can start again using US service providers like AWS, Google Cloud, and Azure, without any trouble (and additional safeguards).
This is thanks to the new Adequacy Decision approved by the EU Commission for the United States.
With the Access Prescription Digital Therapeutics Act, we may witness a change that promises to transform healthcare delivery with benefits for both digital health companies and millions of American citizens.
France has introduced a fast-track market access pathway for DTx and digital health products, adding to similar schemes in neighboring EU countries Germany (DVG for DiGA) and Belgium.
In this blog article, we will go through this topic from the POV of a digital health startup and try to give you a better understanding of when you should ask for consent and why.
Italy’s data protection authority has ordered OpenAI to stop processing people’s data locally with immediate effect. The Italy DPA claims that ChatGPT is breaching the GDPR due to unlawful data processing.
Many digital health companies, afraid of the costs and timeline of a proper GDPR implementation, opt for a strategy to store personal and sensitive data inside the devices, hoping to circumvent the regulation.
After the invalidation of the previous adequacy decision on the EU-US Privacy Shield, the US is still considered TODAY a Third country without an Adequacy Decision according to GDPR.